Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in US Coverage of Pelvic Floor Muscle Therapy.

OBJECTIVE

To evaluate the evidence supporting preventive pelvic floor muscle therapy (PFMT) in reducing pregnancy-associated pelvic floor dysfunction (PFD) and assess the alignment of insurance coverage, clinical guidelines, and legislative initiatives with current evidence in the United States. Despite growing evidence supporting PFMT, US insurers restrict coverage to treatment of dysfunction rather than its prevention.

METHODS

We review the pathophysiologic mechanisms linking childbirth to PFD, summarize the evidence supporting preventive PFMT, and evaluate US insurance coverage practices, PFMT implementation guidelines, and relevant legislation. International approaches to pelvic floor health promotion are also examined.

RESULTS

Vaginal birth places significant mechanical strain on the pelvic floor, frequently injuring the structures responsible for maintaining continence and preventing pelvic organ prolapse (POP). Evidence from a 2020 Cochrane review, RCTs, and other meta-analyses demonstrates that antenatal PFMT significantly reduces the risk of urinary incontinence (UI) during pregnancy and postpartum. The preventive efficacy of postpartum PFMT remains less clearly defined, as many studies evaluate mixed populations of continent and incontinent patients vs strictly continent. US insurance does not cover preventive PFMT, resulting in significant out-of-pocket costs. Clinical and public health guidelines inconsistently address preventive PFMT, and legislative efforts remain limited.

CONCLUSION

Preventive PFMT represents an evidence-based strategy for reducing pregnancy-associated PFD. Aligning clinical guidelines, insurance coverage, and legislative initiatives with current evidence may improve access to preventive pelvic floor care and strengthen maternal health outcomes.